Anticancer activity mechanism and biotechnological obtaining of rinderol - a novel naphthoquinone derivative
2019/33/N/NZ7/01782
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ3_003: Apoptoza
- NZ7_016: Inne zagadnienia pokrewne
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 17 – announced on 2019-03-15
- Amount awarded
- 209 999 PLN
- Project start date
- 2020-03-05
- Project end date
- 2025-03-04
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Polyurethane Foam Rafts Supported In Vitro Cultures of Rindera graeca Roots for Enhanced Production of Rinderol, Potent Proapoptotic Naphthoquinone Compound
- Authors:
- Kawka M., Bubko I., Koronkiewicz M., Gruber-Bzura B., Graikou K., Chinou I., Jeziorek M., Pietrosiuk A., Sykłowska-Baranek K.
- Academic press:
- International Journal of Molecular Sciences (year: 2021, volume: 23, pages: 56), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms23010056 – link to the publication